CM
WST icon

Capula Management’s West Pharmaceutical WST Stock Holding History

Capula Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,190
Closed -$419K – 609
2023
Q4 		$419K Sell
1,190
-110
-8% -$38.9K 0.02% 197
2023
Q3 		$488K Hold
1,300
– – 0.01% 347
2023
Q2 		$497K Sell
1,300
-240
-16% -$85.7K 0.01% 289
2023
Q1 		$534K Sell
1,540
-750
-33% -$219K 0.01% 409
2022
Q4 		$539K Sell
2,290
-1,350
-37% -$320K 0.01% 550
2022
Q3 		$896K Buy
+3,640
New +$1.11M 0.01% 418
2021
Q3 		– Sell
-812
Closed -$291K – 1080
2021
Q2 		$291K Buy
+812
New +$268K ﹤0.01% 587

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Capula Management's WST Position: Q1 2024 in Review

Capula Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,190 shares — an estimated $419K sold.

Capula Management first reported a position in WST in Q2 2021 and held it in 7 quarters. The position peaked at $896K in Q3 2022. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Capula Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Capula Management sold 1,190 West Pharmaceutical shares in Q1 2024, an estimated $419K.
  • Capula Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 7 quarters.
  • Capula Management's West Pharmaceutical position peaked at $896K in Q3 2022.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Capula Management's 13F filing for Q1 2024, filed 9 May 2024.